PMCB icon

PharmaCyte Biotech
PMCB

Overview Fund Activity

31 hedge funds and large institutions have $2.4M invested in PharmaCyte Biotech in 2023 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 8 increasing their positions, 9 reducing their positions, and 2 closing their positions.

Holders
31
Holders Change
+2
Holders Change %
+6.9%
% of All Funds
0.49%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
4
Increased
8
Reduced
9
Closed
2
Calls
$18K
Puts
$4K
Net Calls
+$14K
Net Calls Change
+$353K

Top Buyers

1
KPF
1
K2 Principal Fund
Ontario, Canada
$543K
2
SM
2
Sabby Management
Florida
$204K
3
EPM
3
Equitec Proprietary Markets
Illinois
$174K
4
Renaissance Technologies
4
Renaissance Technologies
New York
$69K
5
TRCT
5
Tower Research Capital (TRC)
New York
$2.56K

Top Sellers

1
AC
1
Ayrton Capital
Connecticut
$193K
2
Citadel Advisors
2
Citadel Advisors
Florida
$74.3K
3
Group One Trading
3
Group One Trading
Illinois
$0
4
Vanguard Group
4
Vanguard Group
Pennsylvania
$355K
5
Northern Trust
5
Northern Trust
Illinois
$40.5K
Name Holding Trade Value Shares
Change 		Shares
Change %
NA
26
NewEdge Advisors
Louisiana
$6 +$2 +1 +50%
CWA
27
Carolina Wealth Advisors
South Carolina
$4 – – –
Group One Trading
28
Group One Trading
Illinois
– -$40.8K -14,282 Closed
Fidelity Investments
29
Fidelity Investments
Massachusetts
– -$3 -1 Closed
1
2